Innate immunity in cystic fibrosis lung disease.
Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview o...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797060353301938176 |
|---|---|
| author | Hartl, D Gaggar, A Bruscia, E Hector, A Marcos, V Jung, A Greene, C McElvaney, G Mall, M Döring, G |
| author_facet | Hartl, D Gaggar, A Bruscia, E Hector, A Marcos, V Jung, A Greene, C McElvaney, G Mall, M Döring, G |
| author_sort | Hartl, D |
| collection | OXFORD |
| description | Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview of innate immunity in CF lung disease, involving (i) epithelial dysfunction, (ii) pathogen sensing, (iii) leukocyte recruitment, (iv) phagocyte impairment, (v) mechanisms linking innate and adaptive immunity and (iv) the potential clinical relevance. Dissecting the complex network of innate immune regulation and associated pro-inflammatory cascades in CF lung disease may pave the way for novel immune-targeted therapies in CF and other chronic infective lung diseases. |
| first_indexed | 2024-03-06T20:15:54Z |
| format | Journal article |
| id | oxford-uuid:2c2336f3-0854-4da0-9453-cdd20cde8944 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:15:54Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:2c2336f3-0854-4da0-9453-cdd20cde89442022-03-26T12:35:10ZInnate immunity in cystic fibrosis lung disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2c2336f3-0854-4da0-9453-cdd20cde8944EnglishSymplectic Elements at Oxford2012Hartl, DGaggar, ABruscia, EHector, AMarcos, VJung, AGreene, CMcElvaney, GMall, MDöring, GChronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview of innate immunity in CF lung disease, involving (i) epithelial dysfunction, (ii) pathogen sensing, (iii) leukocyte recruitment, (iv) phagocyte impairment, (v) mechanisms linking innate and adaptive immunity and (iv) the potential clinical relevance. Dissecting the complex network of innate immune regulation and associated pro-inflammatory cascades in CF lung disease may pave the way for novel immune-targeted therapies in CF and other chronic infective lung diseases. |
| spellingShingle | Hartl, D Gaggar, A Bruscia, E Hector, A Marcos, V Jung, A Greene, C McElvaney, G Mall, M Döring, G Innate immunity in cystic fibrosis lung disease. |
| title | Innate immunity in cystic fibrosis lung disease. |
| title_full | Innate immunity in cystic fibrosis lung disease. |
| title_fullStr | Innate immunity in cystic fibrosis lung disease. |
| title_full_unstemmed | Innate immunity in cystic fibrosis lung disease. |
| title_short | Innate immunity in cystic fibrosis lung disease. |
| title_sort | innate immunity in cystic fibrosis lung disease |
| work_keys_str_mv | AT hartld innateimmunityincysticfibrosislungdisease AT gaggara innateimmunityincysticfibrosislungdisease AT brusciae innateimmunityincysticfibrosislungdisease AT hectora innateimmunityincysticfibrosislungdisease AT marcosv innateimmunityincysticfibrosislungdisease AT junga innateimmunityincysticfibrosislungdisease AT greenec innateimmunityincysticfibrosislungdisease AT mcelvaneyg innateimmunityincysticfibrosislungdisease AT mallm innateimmunityincysticfibrosislungdisease AT doringg innateimmunityincysticfibrosislungdisease |